U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357545) titled 'Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried' on Jan. 05.
Brief Summary: To evaluate the immunogenicity and safety of different post-exposure prophylaxis (PEP) schedules of Sinovac rabies vaccine, in comparison with a marked rabies vaccinein china, in subjects aged 10-60 years old.
Study Start Date: Aug. 27, 2021
Study Type: INTERVENTIONAL
Condition:
Rabies (Healthy Volunteers)
Intervention:
BIOLOGICAL: Sinovac rabies vaccine
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried using three types of PEP schedules
BIOLOGICAL: Marketed rabies vaccine
A markted Rabies Vaccine usi...